Related Topics
Health-harming extreme heat, driven by climate change, on the rise
Excessive heat—the number one killer of all natural disasters—has been on the rise over the past decade, and experts expect it to get worse because of the climate crisis.
Course highlights the health impacts of homelessness
Harvard Chan School's two-year-old course on homelessness and health is one of many pieces of the School’s new pilot Initiative on Health and Homelessness (IHH), an effort aimed at advancing education, research, and practice regarding housing instability’s devastating…
Need help managing diabetes? These students made an app for that
Amber Nigam, SM ’23, and Jie Sun, SM ’22, co-founded a tech startup called basys.ai in order to create an easy-to-use app that helps diabetes patients manage their disease.
Heart-healthy diets may also be brain boosting
Evidence suggests that certain foods or diets may help stave off dementia.
For longevity, aim for 150 minutes of weekly exercise
Experts recommend that people who are physically able to exercise aim for 150 minutes of moderate-intensity activity every week to reap longevity benefits.
Opinion: FDA should boost food industry regulation
The Food and Drug Administration should put renewed emphasis on its underused food-regulatory powers, according to a STAT opinion piece.
Ukraine’s humanitarian crisis
Russia’s invasion of Ukraine has prompted a massive humanitarian crisis, with mounting military and civilian casualties and more than two million people on the move to escape the violence. In this Big 3 Q&A, Michael VanRooyen, director of…
A call to improve care for people with both Medicare and Medicaid
Some of the sickest and most vulnerable patients in the U.S. qualify for both the Medicare and Medicaid programs. But navigating the complex and confusing rules and regulations of the two programs can be daunting, according to Harvard…
Notable news from the world of public health
Updates on vaccines for malaria and HPV, tampons as a human right, how other countries see American health care, and more.
Those at highest risk for severe COVID-19 often least likely to get monoclonal antibodies
People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)—a highly effective treatment for the disease—both across and within U.S. states, according to new research co-authored…
